COVID-19 Serology Laboratory

Overview

Image
Stacked well plates labeled "COVID-19"

The COVID-19 Serology Laboratory establishes standards and coordinates research for the National Cancer Institute Serological Sciences Network (SeroNet).  

At the start of the COVID-19 pandemic in March, 2020, our scientists pivoted to evaluate the performance of SARS-CoV-2 antibody tests for the U.S. Food and Drug Administration. As the NCI established SeroNet, the laboratory grew from its original HPV focus to address COVID-19 serology and immunology.

The COVID-19 Serology Laboratory provides expertise and leadership for SeroNet, which is the largest coordinated effort to better understand SARS-CoV-2 immune response.

Focus

COVID-19 Immune Response 

Serology Standardization

  •     Develop, validate, and standardize serology assays, reagents, and procedures to enable the comparison of different studies evaluating immune responses induced by vaccines.
  •     Provide standardized resources to the scientific community.